СИНТЕЗ ПРОИЗВОДНЫХ ПИРИМИДИН-2,4(Ш,3Щ-ДИОНОВ, СОДЕРЖАЩИХ N-АЛКИЛЬНЫЕ ЗАМЕСТИТЕЛИRASKILDINA, G.Z.,
VALIEV, V.F.,
OZDEN, I.V.,
ZLOTSKII, S.S.,
MESHCHERYAKOVA, S.A.,
SPIRIKHIN, L.V.,
Раскильдина Г.З.,,
Валиев В.Ф.,,
Озден И.В.,,
Мещерякова С.А.,,
Спирихин Л.В.,,
Злотский С.С. (2017) mixture of
N1- and
N3-monosubstituted products, and the profound
N-alkylation of this compound provides
Raskildinaa, G.Z.,
Valieva, V.F.,
Ozdena, I.V.,
Meshcheryakova, S.A.,
Spirikhin, L.V.,
Zlotskiia, S.S. (2017)
mixture of
N1
- and
N3
-monosubstituted products, and the profound
N-alkylation of this compound provides
Раскильдина, Г.З.,
Валиев, В.Ф.,
Озден, И.В.,
Мещерякова, С.А.,
Спирихин, Л.В.,
Злоцкий, С.С.,
Raskildinaa, G.Z.,
Valieva, V.F.,
Ozdena, I.V.,
Meshcheryakova, S.A.,
Spirikhinc, L.V.,
Zlotskii, S.S. (2017) derivatives gives a
mixture of
N1
- and
N3
-monosubstituted products, and the profound
NZagidullin, N.S.,
Dunayeva, A.R.,
Plechev, V.V.,
Gilmanov, A.Z.,
Zagidullin, S.Z.,
Er, F.,
Pavlov, V.N. (2017) . The patients were randomized for RIPC (
n = 26, 60.5 ± 2.0 years) or
12 sRIPC (
n = 25, 62.96 ± 1.7). RIPC